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Abstract
Background: The aim of this study was to ascertain the incidence of and the risk factors associated with morbidity in laparoscopy performed 
on patients with cervical cancer and endometrial cancer.
Methods: This was an observational study of a cohort of 128 women, 89 with endometrial cancer and 39 with cervical cancer from January 
2000 to December 2011. We used the Student’s t-test or the Mann-Whitney U test for continuous variables, and the Chi-square or Fisher’s 
exact test for categorical variables.
Results: Complications were found in 44 patients (34.4%). After a multivariate analysis, among the risk factors associated with the 
presence of complications as the only type of surgery was found to be statistically significant (p = 0.043), more frequent in the most 
complex procedures such as Wertheim operation, trachelectomy, and para-aortic lymphadenectomy. Type of surgery (p = 0.003) and 
tumour type (p = 0.003) were risk factors associated with conversion to laparotomy. It was more frequent among the most complex 
procedures and cervical cancer cases. Regarding the need for transfusion, significant differences were observed in terms of surgery 
duration (p < 0.001), more frequent in longer surgery.
Conclusion: Morbidity in laparoscopic surgical oncology is related to the surgery complexity, where the basal characteristics of the patient 
are not a factor of influence in the development of complications.
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Introduction
The most frequent gynaecologic tumour is endometrial cancer (EC) followed by cervical cancer (CC). Every year 198,000 new cases of EC 
[1] and 500,000 new cases of CC are diagnosed around the world, this being 83% in developed countries [2].
In many patients who suffer from these types of tumours, surgery forms part of their treatment. Because of their baseline disease, these 
cases involve special operative morbidity.
Indeed, it was precisely this goal of reducing operative morbidity and ensuring a better quality of life that led to the development of laparoscopic 
surgery for these tumours. A number of studies have demonstrated the safety and the effectiveness of this procedure as compared to 
conventional laparotomy, with evidence to show that laparoscopy results in a shorter hospital stay, lower morbidity, and the same survival rate 
[3–6]. In the case of EC, it should be noted that the Gynaecologic Oncology Group’s LAP2 study showed that at three years there were no 
differences in overall survival (OS) among patients who had undergone laparoscopic or laparotomic surgery (89.8% versus 89.9%) [7]; and in 
the case of CC, a follow-up study of laparoscopy patients reported 92.7% OS and 91.1% disease-free survival (DFS) at 7.2 years [8].
Our study aimed at ascertaining the complications inherent in this type of patients in view of the fact that, while laparoscopy is widely reputed 
to be a safe surgical technique with a very low percentage (0–10%) of complications [9–11], the relevant data have nevertheless been drawn 
from different series which have largely included benign surgical processes. We thus thought it would be of interest to ascertain the incidence 
of complications in laparoscopy performed in oncologic patients who present with greater morbidity owing to the surgical difficulty entailed 
and their baseline disease. Moreover, this subject has been addressed by few studies directly.
Methods
We conducted an observational study on a cohort of EC and CC patients who underwent laparoscopy at the Gynaecology Department of 
the POVISA Hospital, (Vigo, Spain), from January 2000 until December 2011. This study was undertaken with the approval of the Galician 
Clinical Research Ethics Committee. Excluded from the study were: patients who did not undergo monitoring at the above health centre, 
defined as a three month follow-up period for study assessment purposes; and those whose clinical history did not allow collection of data 
on the study variables.
The variables were retrospectively collected by a review of clinical histories. We analysed patient characteristics, such as age, pre- and postop-
erative haemoglobin (Hb) in g/dL, body mass index (BMI; patient’s weight in kilograms divided by height in meters squared), previous abdominal 
surgery, and comorbidities (arterial hypertension, diabetes mellitus, thyroid disorders, chronic treatment with corticosteroids or immunomodula-
tory drugs). In the case of tumour characteristics, we recorded histologic type, grade, Federation of Obstetricians and Gynaecologists (FIGO) 
stage, and lymph node involvement. Types of surgery are stratified depending on the level of complexity: Level 1 (hysterectomy +/- double adn-
exectomy), level 2 (all surgery procedures with pelvic lymphadenectomy), and level 3 (Wertheim, trachelectomy and surgery procedures with 
para-aortic lymphadenectomy). Regarding the surgical technique used, the following variables were included: presence of adhesions, number 
of resected lymph nodes, and surgery duration (minutes). Surgeons’ experience was evaluated in years dating back from their first advanced 
laparoscopy. Complications were divided into intra- and postoperative (i.e. diagnosed in the first three months post-surgery), and included nerve, 
intestinal, urologic, and vascular lesions, ileum, lymphocysts, fistulae, bladder dysfunction, infection, haemoperitoneum, thromboembolic events, 
and trocar site hernia. Other data collected included the need for and cause of conversion to laparotomy, and the use of blood transfusions.
For the analysis of risk factors according to BMI, patients were divided into the following two groups: those with a BMI of less than 30; and 
those that presented with overweight and obesity, namely a BMI of 30 or over. We identified patients with postoperative anaemia, defined 
as any person who had a lower postoperative Hb of 11.5 g/dL, or who on comparing pre- and postoperative Hb levels registered a decline 
of 3 g/dL or more. Similarly, tumours were categorised as advanced or early FIGO stage, with early stage being defined as I–II in EC and 
as I–IIa in CC, and advanced stage being defined as III–IV in EC and as IIb–IV in CC. 
Statistical analysis
Continuous variables were expressed as the median (interquartile range) and categorical covariates as percentages. The association 
between each of the study variables with (a) type of cancer, (b) complications, (c) conversion to laparotomy, and (d) transfusion was sta-
tistically analysed using the Student’s t-test or the Mann-Whitney U test for continuous variables, and the Chi-square or Fisher’s exact 
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test for categorical variables. Variables having a p-value of less than 0.2 in the univariate analysis were incorporated into a multivariate 
logistic regression model that also included age, regardless of its statistical significance in the univariate analysis. A stepwise procedure 
based on the Wald test was then used to select the best subset of explanatory risk factors, while maintaining type of cancer and age as 
possible confounding variables in the regression model. Results were expressed as Odds Ratios (ORs) along with their 95% confidence 
intervals (CI). All tests were two-sided, with P < 0.05 regarded as statistically significant. We performed all the analysis using the R software 
programme, version 2.15.1 [12].
Results
A total of 128 patients were analysed, 89 with EC and 39 with CC. The characteristics of both groups are described in Table 1, which 
shows that these two groups are differentiated in terms of patient’s baseline characteristics and surgery type, but no differences in terms 
of FIGO stage and existence of previous surgery.
Table 1. Patient characteristics by type of cancer.
Characteristics
Type of cancer
p-valueEndometrial
(n = 89)
Cervical
(n = 39)
Age 64.0 [56.0; 71.0] 49.0 [39.0; 56.0] <0.001
BMI
≤30
>30
45 (52.9%)
40 (47.1%)
32 (84.2%)
6 (15.8%)
0.002
Comorbidities
No
Yes
37 (41.6%)
52 (58.4%)
29 (74.4%)
10 (25.6%)
0.001
Arterial hypertension
No
Yes
52 (58.4%)
37 (41.6%)
34 (87.2%)
5 (12.8%)
0.003
Diabetes mellitus
No
Yes
76 (85.4%)
13 (14.6%)
38 (97.4%)
1 (2.6%)
0.063
Thyroid disease
No 
Yes
76 (85.4%)
13 (14.6%)
38 (897.4%)
1 (2.6%)
0.063
Corticosteroids
No
Yes
98 (100%)
0 (0%)
37 (94.9%)
2 (5.1%)
0.091
Immunomodulatory treatments
No
Yes
88 (98.9%)
1 (1.1%)
34 (87.2%)
5 (12.8%)
0.010
Previous abdominal surgery
No
Yes
54 (60.7%)
35 (39.3%)
28 (71.8%)
11 (28.2%)
0.314
FIGO stage
Early
Advanced
77 (86.5%)
12 (13.5%)
33 (91.7%)
3 (8.3%)
0.551
Surgery
Level 1
Level 2
Level 3
23 (25.8%)
59 (66.3%)
7 (7.87%)
4 (10.3%)
1 (2.5%)
34 (87.2%)
<0.001
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EC group is formed in majority by endometrioid adenocarcinoma cases i.e. a total of 78. The rest being two cases of serous adenocarcinoma, 
carcinosarcoma and adenocarcinoma mixed carcinoma (endometrioid and clear cell) and one case of polypoid carcinosarcoma, endometrial 
leiomyosarcoma, clear cell adenocarcinoma, papillar adenocarcinoma, and squamous adenocarcinoma. The distribution by FIGO stage is 
shown in Table 1. The histological grade (G) distribution is conformed by 28 G1, 34 G2, and 25 G3, and for only two cases we did not find 
data in their clinical histories.
Histological distribution CC group is formed by squamous carcinoma 22 cases, adenocarcinoma 12 cases, adenosquamous 2 cases, 
1 neuroendocrine tumour, and 1 granulosa cell tumour. Table 1 shows the number of cases by FIGO stage. By grade we found, 4 G1, 
11 G2 and 10 G3, and there were 14 cases without data available about that.
The type of surgery performed and its distribution according to surgeons’ experience are shown in Table 2. The median hospital stay was 
seven days.
There were complications in a total of 44 patients, 22 cases in EC, and 22 cases in CC, an overall incidence of 34.4%. Despite this morbidity 
percentage, the mortality showed in the follow-up was 0%. 
The different types of complications were: intraoperative complications, which include nerve lesion, vascular lesion and urologic lesion; 
and postoperative complications of: obstructive uropathy, ileum, lymphocysts, fistulae, bladder dysfunction, infection, haemoperitoneum, 
thromboembolic disease, trocar site hernia, and other complications. Intraoperative complications were less frequent (19 cases); they 
mostly took the form of vascular lesions (12 cases). Postoperative complications (54 cases) were more heterogeneously distributed, with 
trocar site hernia and thromboembolic events being the most frequent, in eight and seven cases respectively. Under the header of ‘other 
complications’ were included: abdominal wall haematoma; respiratory distress syndrome; paroxysmal atrial fibrillation; pulmonary oedema; 
drain entrapment; trocar site tumour recurrence; rectus sheath haematoma; seroma; and pleural effusion. If we use the Clavien-Dindo 
grading system to classify postoperative complications, the distribution is as seen in Table 3. We find that the most frequent are type III i.e. 
those which need surgery consisting of 22 cases, majority of them because of trocar site hernia which amount to a total of eight cases. The 
second in frequency with five cases is obstructive uropathy. On the other side type IV, complications that need intermediate or intensive 
care included only six cases, five with total pulmonary thromboembolism. Those with minor complications which have a pharmacological 
solution, i.e. type I and II conformed as the majority group with 26 cases. [13].
Table 2. Overall distribution of types of surgery, according to surgeons’ experience.
Type of surgery Number of cases(n = 128)
Surgeons’ experience in years
≤5
(n = 44)
>5
(n = 84)
Level 1* 27 (21.1%) 11 (25.0%) 16 (19.0%)
Level 2† 60 (46.9%) 20 (45.5%) 40 (47.6%)
Level 3‡ 41 (32.0%) 13 (29.5%) 28 (33.3%)
*Hysterectomy +/- bilateral adnexectomy.
†Surgery with pelvic lymphadenectomy.
‡Wertheim, trachelectomy, surgery with para-aortic lymphadenectomy.
Table 3. Postoperative complications distribution according 
Clavien-Dindo grading system.
Grade Number complications (%)
I 16 (29.6%)
II 10 (18.5%)
III 22 (40.7%)
IV 6 (11%)
V 0 (0%)
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Table 4. Risk factors and presence of complications.
Variable
Complications
p-value
No (n = 84) Yes (n = 44)
Type of cancer
Endometrial
Cervical
67 (79.8%)
17 (20.2%)
22 (50%)
22 (50%)
0.001
Age 62.5 [51.0; 69.2] 56.0 [48.2; 62.5] 0.032
Surgery duration 172 [129; 230] 244 [155; 310] 0.006
BMI
≤30
>30
49 (61.3%)
31 (38.8%)
28 (65.1%)
15 (34.9%)
0.820
Previous abdominal surgery
No
Yes
54 (64.3%)
30 (35.7%)
28 (65.1%)
16 (34.9%)
1.000
Adhesions
No
Yes
66 (78.6%)
18 (21.4%)
38 (86.4%)
6 (13.6%)
0.404
Comorbidities
No
Yes
40 (47.6%)
44 (52.4%)
26 (59.1)
18 (40.9%)
0.295
Smoking
Non-smoker
Smoker
71 (84.5%)
13 (15.5%)
34 (77.3%)
10 (22.7%)
0.440
Alcohol
Yes
No
61 (72.6%)
23 (27.4%)
28 (63.6%)
16 (36.4%)
0.397
FIGO Stage
Early
Advanced
69 (85.2%)
12 (14.8%)
41 (93.2%)
3 (6.8%)
0.305
Radio + Chemo
No
Yes
81 (96.4%)
3 (3.6%)
43 (97.7%)
1 (2.3%)
1.000
Surgeons’ experience
≤five years
>five years
33 (39.3%)
51 (60.7%)
11 (25.0%)
33 (75.0%)
0.156
Type of surgery
Level 1
Level 2
Level 3
19 (22.6%)
48 (57.1%)
17 (20.2%)
8 (18.2%)
12 (27.3%)
24 (54.5%)
<0.001
After fulfilling the univariant analysis, the risk factors statistically significant in relation to the development of complications are: type of 
cancer, age, surgical time, and type of surgery, as shown in Table 4. When applying the multivariant analysis the only risk factor is type 
of surgery, complications being more frequent in more complex surgeries, level 3 (p-value 0.043). The type of complications related to 
surgical processes level 3 are: vascular lesion, fistulas, bladder dysfunction, and infection, showing statistical significance in Table 5.
Even though surgeons’ experience is not presented as a risk factor, when breaking down the complications according to the surgeons’ 
experience, Table 6, less experienced surgeons present a higher risk of hernia through the trocar, one of the most frequent postsurgical 
complications.
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Table 5. Complications according to type of surgery.
Complications
Type of Surgery
p-valueLevel 1
(n = 27)
Level 2
(n = 60)
Level 3
(n = 41)
Intraoperative
Nerve lesion
No
Yes
27 (100%)
0 (0.0%)
59 (98.3%)
1 (1.7%)
41 (100%)
0 (0.0%)
1.000
Vascular lesion 
No
Yes
25 (92.6%)
2 (7.4%)
58 (96.7%)
2 (3.3%)
33 (80.5%)
8 (19.5%)
0.023
Intestinal lesion
No 27 (100%) 60 (100%) 41 (100%)
Urologic lesion
No
Yes
26 (96.3%)
1 (3.7%)
59 (98.3%)
1 (1.7%)
37 (90.2%)
4 (9.8%)
0.155
Postoperative
Obstructive uropathy
No
Yes
27 (100%)
0 (0.0%)
59 (98.3%)
1 (1.7%)
37 (90.2%)
4 (9.8%)
0.107
Ileum
No
Yes
25 (92.6%)
2 (7.4%)
60 (100%)
0 (0.0%)
40 (97.6%)
1 (2.4%)
0.082
Lymphocysts
No
Yes
27 (100%)
0 (0.0%)
58 (96.7%)
2 (3.3%)
37 (90.2%)
4 (9.8%)
0.219
Fistulae
No 
Yes
27 (100%)
0 (0.0%)
60 (100%)
0 (0.0%)
38 (92.7%)
3 (7.3%)
0.040
Bladder dysfunction
No
Yes
27 (100%)
0 (0.0%)
60 (100%)
0 (0.0%)
35 (85.4%)
6 (14.6%)
0.001
Infection
No
Yes
26 (93.6%)
1 (3.7%)
60 (100%)
0 (0.0%)
37 (90.2%)
4 (9.8%)
0.029
Haemoperitoneum
No 
Yes
27 (100%)
0 (0.0%)
59 (98.3%)
1 (1.7%)
40 (97.6%)
1 (2.4%)
1.000
Thromboembolic disease
No
Yes
25 (92.6%)
2 (7.4%)
58 (96.7%)
2 (3.3%)
38 (92.7%)
3 (7.3%)
0.603
Trocar site hernia
No 
Yes
25 (92.6%)
2 (7.4%)
58 (96.7%)
2 (3.3%)
37 (90.2%)
4 (9.8%)
0.452
Other complications
No 
Yes
26 (93.6%)
1 (3.7%)
55 (91.7%)
5 (8.3%)
37 (90.2%)
4 (9.8%)
0.766
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Table 6. Complications according to the surgeon’s experience.
Complications
Surgeon’s experience
p-value≤five years
(n = 44)
>five years
(n = 84)
Intraoperative
Nerve lesion
No
Yes
44 (100%)
0 (0.0%)
83 (98.8%)
1 (1.2%)
1.000
Vascular lesion 
No
Yes
43 (97.7%)
1 (2.3%)
73 (86.9%)
11 (13.1%)
0.057
Intestinal lesion
No 44 (100%) 84 (100%)
–
Urologic lesion
No
Yes
42 (95.5%)
2 (4.5%)
80 (95.2%)
4 (4.8%)
1.000
Postoperative
Obstructive uropathy
No
Yes
41 (93.2%)
3 (6.8%)
82 (97.6%)
2 (2.4%)
0.338
Ileum
No
Yes
42 (95.5%)
2 (4.5%)
83 (98.8%)
1 (1.2%)
0.272
Lymphocysts
No
Yes
43 (97.7%)
1 (2.3%)
79 (94.0%)
5 (6.0%)
0.663
Fistulae
No 
Yes
44 (100%)
0 (0.0%)
81 (96.4%)
3 (3.6%)
0.551
Bladder dysfunction
No
Yes
43 (97.7%)
1 (2.3%)
79 (94.0%)
5 (6.0%)
0.663
Infection
No
Yes
42 (95.5%)
2 (4.5%)
81 (96.4%)
3 (3.6%)
1.000
Haemoperitoneum
No 
Yes
44 (100%)
0 (0.0%)
82 (97.6%)
2 (2.4%)
0.545
Thromboembolic disease
No
Yes
43 (97.7%)
1 (2.3%)
78 (92.9%)
6 (7.1%)
0.421
Trocar site hernia
No 
Yes
38 (86.4%)
6 (13.6%)
82 (97.6%)
2 (2.4%)
0.020
Other complications
No 
Yes
43 (97.7%)
1 (2.3%)
75 (89.3%)
9 (10.7%)
0.163
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Studying specific risk factors, the influence of the number of lymph nodes extracted on the development of lymphocysts did not prove to be 
statistically significant. Patients with lymphocysts presented with a median of 13 resected lymph nodes compared with a median of 12.5 in 
the group of patients without lymphocysts (p-value 0.76).
Furthermore, a study of the relationship between the development of thromboembolic events on the one hand and duration of surgery 
and BMI on the other, showed that surgery in patients with thrombosis had a median duration of 170 as opposed to 185 minutes in those 
without thrombotic involvement, with no significant differences in evidence (p-value 0.8). In the case of BMI, a comparison of patients who 
presented thrombosis showed no statistically significant difference between those with a BMI of under 30 and those with a BMI of 30 or 
over, with the respective figures being 57.1% versus 42.9% (p-value 1.00).
The relation of the BMI is analysed with the development of vascular and urologic lesions, being in both cases not relevant, with p- value 
of 0.7 and 0.1 respectively.
The factors associated with the need for transfusion or conversion to laparotomy are analysed in Table 7. Regarding the transfusions, significant 
differences were observed in terms of type of cancer, with transfusion proving more frequent in CC than in EC, 59.9% versus 26.4%, in longer 
surgical procedures (254 minutes versus 169 minutes), and in type of surgery, more frequent in level 3, i.e. 54.3%. After applying the multivariate 
model, the only statistically significant factor was surgery duration (p-value <0.001). 
The statistically significant risk factors for conversion to laparotomy were type of cancer and type of surgery, with conversion being more 
frequent in CC than in EC, 14.4% versus 2.2%, and in patients with surgery level 3 this being 85.7%. The mentioned factors could not been 
confirmed applying a multivariate model, since there were no cases of conversion in surgery level 2.
Discussion
In our series, the incidence of complications is 34.4%. This might be regarded as a high figure compared with a previous paper [10] that 
analysed complications in a Gynaecologic Oncology Service and reported a 9% complication rate in 1451 laparoscopies. However, this 
group covered all types of interventions, including diagnostic and second-look laparoscopies, salpingectomies, etc. Among these there were 
only 79 high-level procedures, of which two were radical hysterectomies. Closer to our percentage of complications are other studies which 
addressed laparoscopy in EC [3, 4, 5, 6, 14] and reported complication rates ranging from 5–33%. It should however, be stressed here that 
whereas many of these studies covered laparoscopies which were mainly performed on stage-I cases, our sample also included 15 cases in 
stages III–IV. In the case of CC, there are fewer studies. By extension in one study with a smaller volume of patients; [8] i.e. with 139 cases 
of CC, reported a complication rate of 21.58%.
The percentage of conversions to laparotomy in our sample was 5.47%, which comes within the range cited by some randomised studies, 
i.e., 2.4–25.8% [6], with the highest figure, 25.8%, being reported by the LAP2 study. The risk factors related to the conversion to laparotomy 
are the type of surgery and the type of tumour, being more frequent in more complex surgeries and CC. Both factors seem to be related, since 
in all CC more complex surgeries are conducted. It should be underlined that in our sample, six out of seven cases of conversion to laparotomy 
were vascular lesions that could not be controlled through laparoscopy.
On seeking to identify possible risk factors for development of complications, significant differences were only observed with respect to 
surgery type, more frequent in level 3. Analysis of the distribution of the different types of complications in our sample showed that there 
were significant differences in terms of development of fistulae, bladder dysfunction, infection, and vascular lesions, with all of these being 
more frequent among women undergoing surgery level 3. Other publications support that the difficulty of surgical procedures is a risk factor 
in the development of complications [9], especially the laparoscopic radical hysterectomy is associated with a significant increased risk of 
intraoperative urologic complications [15]. Although there is a clear risk of urinary lesions during radical hysterectomy, this is not increased 
by laparoscopy. Instead, the percentage remains the same as for laparotomy, as shown by one study [16] which reported an intraoperative 
urologic lesion rate of 8% for laparoscopy versus 10.4% for laparotomy, and a postoperative urologic lesion rate of 14% for laparoscopy 
versus 22.9% for laparotomy.
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Table 7. Risk factors in transfusion and conversion to laparotomy.
Transfusion
p-value
Conversion 
p-value
Variable No(n = 82)
Yes
(n = 46)
No
(n = 121)
Yes
(n = 7)
Type of cancer
Endometrial
Cervical
66 (80.5%)
16 (19.5%)
23 (50%)
23 (50%)
0.001 88 (72.7%)
33 (27.3%)
1 (14.3%)
6 (85.7%)
0.003
Age 61 [53; 68] 56 [44.8; 66.8] 0.177 60 [50; 68] 50 [39.5; 56.5] 0.069
Surgery duration 167 [125; 218] 248 [174; 335] <0.001 180 [135; 250] 270 [225; 310] 0.064
BMI
≤30
>30
44 (56.4%)
34 (43.6%)
33 (73.3%)
12 (26.7%)
0.094 71 (60.7%)
46 (39.3%)
6 (100%)
0 (0.0%)
0.083
Previous abdominal surgery
No
Yes
54 (65.9%)
28 (34.1%)
28 (60.9%)
18 (39.1%)
0.710 77 (63.6%)
44 (36.4%)
5 (71.4%)
2 (28.6%)
1.000
Adhesions
No
Yes
67 (81.7%)
15 (18.3%)
37 (80.4%)
9 (19.6%)
1.000 98 (81.0%)
23 (19.0%)
6 (85.7%)
1 (14.3%)
1.000
Comorbidities
No
Yes
39 (47.6%)
43 (52.4%)
27 (58.7%)
9 (41.3%)
0.305 61 (50.4%)
60 (49.6%)
5 (71.4%)
2 (28.6%)
0.442
Smoking
Non-smoker
Smoker
68 (82.9%)
14 (17.1%)
37 (80.4%)
9 (19.6%)
0.910 101 (83.5%)
20 (16.5%)
4 (57.1%)
3 (42.9%)
0.109
Alcohol
No 
Yes
56 (68.3%)
26 (31.7%)
33 (71.7%)
13 (28.3%)
0.837 83 (68.6%)
38 (31.4%)
6 (85.7%)
1 (14.3%)
0.675
FIGO Stage
Early
Advanced
70 (87.5%)
10 (12.5%)
40 (88.9%)
5 (11.1%)
1.000 104 (88.1%)
14 (11.9%)
6 (85.7%)
1 (14.3%)
1.000
Radio + Chemo
No
Yes
80 (97.6%)
2 (2.4%)
44 (95.7%)
2 (4.3%)
0.618 117 (96.7%)
4 (3.3%)
7 (100%)
0 (0.0%)
1.000
Surgeons’ experience
≤five years
>five years
27 (32.9%)
55 (67.1%)
17 (37.0%)
29 (63.0%)
0.790 43 (35.5%)
78 (64.5%)
1 (14.3%)
6 (85.7%)
0.421
Type of Surgery
Level 1
Level 2
Level 3
21 (25.6%)
45 (54.9%)
16 (19.5%)
6 (13.0%)
15 (32.6%)
25 (54.3%)
<0.001
26 (21.5%)
20 (49.6%)
35 (28.9%)
1 (14.3%)
0 (0.0%)
6 (85.7%)
0.003
A recent study related obesity with a higher risk of urologic lesion [15], which lead us to analyse if the BMI influences the urologic lesions, 
but no statistical significance was found (p-value = 0.7). BMI did not affect the subsequent development of complications, conversion to 
laparotomy and need transfusion, a finding in line with other publications [1, 17].
While states of anaemia have been associated with the development of postoperative infections [18], no causal relationship was observed 
in our sample because there were only five cases of infection. Nevertheless, all of these cases of infection occurred in anaemic patients.
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Prolonged surgery durations have been related with nerve lesions [6], some hypotheses found in the literature regarding this are the 
patient’s exposure to anesthesia and the persistence of positions that can cause maintained compression. In our study there was only one 
nerve lesion hence no analysis could be performed in this respect. It has to be said, however, that this intervention lasted 125 minutes, very 
much below the mean surgery time for the total sample, which was 205 minutes.
The percentage of adhesions developed after abdominal surgery was in the order of 21% [19]. The presence of adhesions can hinder 
an intervention and so raise the risk of complications. Nevertheless, as Table 3 shows, neither the existence of previous surgery nor the 
presence of adhesions increased the risk of subsequent complications.
It should be pointed out that, in our sample, operations were performed on four patients who had previously received radio- and/or 
chemotherapy treatment, something that could increase operative morbidity. Even so, there are too few cases for any conclusion to 
be drawn in this respect. Of these four patients, only one presented a complication, with a vascular lesion at the level of the inferior 
epigastric artery.
The incidence of port-site metastasis was very low and stood at around 0.41–0.97% [20, 21]. Its presence has been related with more 
advanced cases of cancer or patients with worse prognosis, positive lymph nodes, carcinomatosis, or metastatic disease spread to other 
parts of the body. In our study there was only one case, which amounted to an incidence of 0.77%, involving a patient with a FIGO stage 
IB-G II endometrioid adenocarcinoma with negative lymph nodes.
To unify the sample, univariate and multivariate analysis were conducted excluding the high rank tumours and doing different analysis for 
cervix and endometrial cancer. This does not add any new interesting data to the original sample of 128 cases, where the risk factor for the 
complications and conversion to laparotomy is type of surgery and the risk factor for need of transfusion is surgery time.
Among the limitations of our study is the fact that it was based on a small number of cases and that it was retrospective. Despite these 
limitations, the results show that the radical nature of the type of intervention performed constituted the principal risk factor for develop-
ment of complications and conversion to laparotomy. The patient’s basal characteristics (obesity, previous surgeries, etc.) do not imply 
a higher surgical morbidity. From this it can be inferred that in the case of oncologic patients, laparoscopic surgery is safe but that the 
specific intervention performed will dictate the final outcome.
Conclusion
Morbidity in laparoscopic surgical oncology is related to the surgery complexity, where the basal characteristics of the patient are not a 
factor of influence on the development of complications.
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